Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Solys Diagnostics is a healthcare diagnostics company and majority-owned subsidiary of PAVmed focused on developing non-invasive diagnostic technologies. The company was created to advance laser-based diagnostic products, initially centered on non-invasive glucose monitoring for diabetes management. Public disclosures indicate Solys was formed in 2019 and entered into agreements with Airware and Liquid Sensing around NDIR laser technology developed by Dr. Jacob Wong. Subsequent PAVmed updates stated that Solys terminated the third-party license arrangement and shifted to advancing its own proprietary non-invasive glucose monitoring technology. Based on available public information, Solys appears to remain an active subsidiary-level development program rather than a standalone commercial diagnostics business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Solys Diagnostics.